| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Height | 54 | 2022 | 1586 | 6.580 |
Why?
|
| Genome-Wide Association Study | 125 | 2024 | 12432 | 3.890 |
Why?
|
| Polymorphism, Single Nucleotide | 179 | 2024 | 15657 | 3.880 |
Why?
|
| Genetic Variation | 82 | 2020 | 6567 | 3.090 |
Why?
|
| Genetic Loci | 30 | 2024 | 2614 | 2.160 |
Why?
|
| Growth Disorders | 13 | 2023 | 646 | 1.860 |
Why?
|
| Genome, Human | 41 | 2022 | 4446 | 1.730 |
Why?
|
| Genetic Predisposition to Disease | 99 | 2024 | 17635 | 1.720 |
Why?
|
| Linkage Disequilibrium | 43 | 2022 | 1999 | 1.670 |
Why?
|
| Quantitative Trait Loci | 26 | 2023 | 2049 | 1.650 |
Why?
|
| Genetics, Population | 21 | 2015 | 938 | 1.600 |
Why?
|
| Gene Frequency | 48 | 2022 | 3591 | 1.580 |
Why?
|
| Multifactorial Inheritance | 16 | 2024 | 1258 | 1.350 |
Why?
|
| Obesity | 52 | 2024 | 12868 | 1.350 |
Why?
|
| Metabolome | 6 | 2020 | 921 | 1.330 |
Why?
|
| Chromosome Mapping | 30 | 2022 | 4723 | 1.330 |
Why?
|
| Body Mass Index | 61 | 2024 | 12821 | 1.280 |
Why?
|
| Quantitative Trait, Heritable | 14 | 2020 | 544 | 1.250 |
Why?
|
| Genetic Linkage | 18 | 2012 | 2409 | 1.210 |
Why?
|
| Genetic Association Studies | 17 | 2020 | 2711 | 1.200 |
Why?
|
| Genetic Diseases, Inborn | 8 | 2016 | 600 | 1.180 |
Why?
|
| Phenotype | 68 | 2023 | 16484 | 1.150 |
Why?
|
| Steroidogenic Factor 1 | 2 | 2016 | 46 | 1.140 |
Why?
|
| Genotype | 81 | 2023 | 12970 | 1.130 |
Why?
|
| 46, XX Disorders of Sex Development | 2 | 2016 | 33 | 1.120 |
Why?
|
| Asthma | 10 | 2018 | 6089 | 1.120 |
Why?
|
| Models, Genetic | 18 | 2016 | 3489 | 1.100 |
Why?
|
| Haplotypes | 40 | 2022 | 2776 | 1.060 |
Why?
|
| Diabetic Nephropathies | 12 | 2022 | 976 | 1.060 |
Why?
|
| Rhinovirus | 2 | 2016 | 191 | 1.020 |
Why?
|
| Dwarfism | 6 | 2015 | 143 | 0.940 |
Why?
|
| Puberty | 8 | 2023 | 492 | 0.940 |
Why?
|
| Growth Plate | 3 | 2021 | 275 | 0.920 |
Why?
|
| Fatty Liver | 6 | 2018 | 736 | 0.890 |
Why?
|
| Lactase | 4 | 2015 | 70 | 0.870 |
Why?
|
| Selection, Genetic | 6 | 2020 | 920 | 0.860 |
Why?
|
| Growth Hormone | 3 | 2021 | 706 | 0.820 |
Why?
|
| Human Growth Hormone | 4 | 2021 | 687 | 0.800 |
Why?
|
| Sequence Analysis, DNA | 15 | 2018 | 4806 | 0.750 |
Why?
|
| Dwarfism, Pituitary | 1 | 2020 | 47 | 0.730 |
Why?
|
| Genomics | 12 | 2022 | 5743 | 0.720 |
Why?
|
| Genetics, Medical | 3 | 2017 | 341 | 0.690 |
Why?
|
| Humans | 329 | 2024 | 752741 | 0.680 |
Why?
|
| Mutation, Missense | 15 | 2020 | 2559 | 0.680 |
Why?
|
| DNA Copy Number Variations | 9 | 2017 | 2009 | 0.680 |
Why?
|
| Alleles | 35 | 2019 | 6954 | 0.670 |
Why?
|
| Fetal Hemoglobin | 6 | 2011 | 342 | 0.670 |
Why?
|
| Extravascular Lung Water | 1 | 2018 | 20 | 0.640 |
Why?
|
| Puberty, Delayed | 7 | 2023 | 115 | 0.630 |
Why?
|
| RNA Splice Sites | 2 | 2016 | 213 | 0.630 |
Why?
|
| Menarche | 7 | 2013 | 522 | 0.620 |
Why?
|
| Metabolomics | 5 | 2020 | 1529 | 0.620 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2020 | 270 | 0.610 |
Why?
|
| Biological Specimen Banks | 3 | 2020 | 726 | 0.610 |
Why?
|
| Conserved Sequence | 3 | 2012 | 1191 | 0.600 |
Why?
|
| Ovotesticular Disorders of Sex Development | 1 | 2016 | 4 | 0.590 |
Why?
|
| Waist-Hip Ratio | 15 | 2019 | 517 | 0.590 |
Why?
|
| Inheritance Patterns | 4 | 2020 | 339 | 0.580 |
Why?
|
| Founder Effect | 2 | 2014 | 191 | 0.570 |
Why?
|
| Diabetes Mellitus, Type 2 | 36 | 2022 | 11909 | 0.570 |
Why?
|
| Adiposity | 11 | 2019 | 1823 | 0.560 |
Why?
|
| Diabetes Mellitus, Type 1 | 11 | 2022 | 3374 | 0.550 |
Why?
|
| Lipids | 8 | 2022 | 3326 | 0.530 |
Why?
|
| Mutation | 23 | 2019 | 29981 | 0.530 |
Why?
|
| Meta-Analysis as Topic | 11 | 2016 | 1364 | 0.530 |
Why?
|
| Anthropometry | 12 | 2017 | 1357 | 0.530 |
Why?
|
| Mendelian Randomization Analysis | 9 | 2024 | 999 | 0.520 |
Why?
|
| Picornaviridae Infections | 1 | 2016 | 91 | 0.510 |
Why?
|
| Genetic Markers | 9 | 2016 | 2633 | 0.500 |
Why?
|
| Computational Biology | 7 | 2020 | 3531 | 0.490 |
Why?
|
| Hypogonadism | 5 | 2023 | 802 | 0.470 |
Why?
|
| Body Weight | 13 | 2018 | 4703 | 0.470 |
Why?
|
| Fluid Therapy | 1 | 2018 | 590 | 0.470 |
Why?
|
| Male | 168 | 2024 | 354311 | 0.470 |
Why?
|
| Population | 1 | 2014 | 142 | 0.470 |
Why?
|
| Frameshift Mutation | 2 | 2013 | 399 | 0.460 |
Why?
|
| Software | 10 | 2018 | 4460 | 0.460 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 780 | 0.450 |
Why?
|
| Cohort Studies | 60 | 2020 | 40939 | 0.450 |
Why?
|
| Immunoglobulin E | 2 | 2017 | 1485 | 0.450 |
Why?
|
| Female | 177 | 2024 | 385090 | 0.450 |
Why?
|
| Homeostasis | 3 | 2019 | 3343 | 0.450 |
Why?
|
| Cullin Proteins | 2 | 2022 | 183 | 0.440 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2014 | 3901 | 0.440 |
Why?
|
| Molecular Sequence Annotation | 2 | 2018 | 529 | 0.440 |
Why?
|
| Principal Component Analysis | 8 | 2020 | 942 | 0.440 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2023 | 3605 | 0.440 |
Why?
|
| Lipase | 3 | 2013 | 313 | 0.430 |
Why?
|
| Body Fat Distribution | 6 | 2019 | 244 | 0.430 |
Why?
|
| Membrane Proteins | 12 | 2014 | 7941 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 283 | 0.420 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2016 | 551 | 0.400 |
Why?
|
| Steroid Hydroxylases | 1 | 2011 | 96 | 0.400 |
Why?
|
| Lipid Metabolism | 2 | 2018 | 1883 | 0.400 |
Why?
|
| Child | 51 | 2024 | 78594 | 0.400 |
Why?
|
| Duodenum | 1 | 2015 | 487 | 0.400 |
Why?
|
| Receptor, Melanocortin, Type 4 | 4 | 2019 | 129 | 0.400 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2215 | 0.390 |
Why?
|
| Gene Pool | 2 | 2011 | 35 | 0.390 |
Why?
|
| Insulin-Like Growth Factor I | 6 | 2020 | 2002 | 0.390 |
Why?
|
| Hemoglobins | 3 | 2016 | 1537 | 0.390 |
Why?
|
| Muscle Hypotonia | 1 | 2012 | 165 | 0.380 |
Why?
|
| DNA-Binding Proteins | 12 | 2022 | 9664 | 0.380 |
Why?
|
| Proteins | 9 | 2019 | 6093 | 0.380 |
Why?
|
| Hemoglobinopathies | 2 | 2010 | 95 | 0.380 |
Why?
|
| Body Size | 6 | 2017 | 461 | 0.370 |
Why?
|
| Feeding Behavior | 3 | 2020 | 3204 | 0.370 |
Why?
|
| Disease | 3 | 2014 | 674 | 0.360 |
Why?
|
| Pyrophosphatases | 2 | 2007 | 138 | 0.350 |
Why?
|
| Adolescent | 51 | 2024 | 86713 | 0.340 |
Why?
|
| Europe | 9 | 2022 | 3359 | 0.340 |
Why?
|
| Clinical Medicine | 1 | 2011 | 147 | 0.340 |
Why?
|
| Databases, Nucleic Acid | 2 | 2016 | 211 | 0.340 |
Why?
|
| Allelic Imbalance | 2 | 2016 | 77 | 0.340 |
Why?
|
| Case-Control Studies | 48 | 2019 | 21904 | 0.330 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2007 | 199 | 0.330 |
Why?
|
| Kidney Failure, Chronic | 8 | 2021 | 2499 | 0.330 |
Why?
|
| Gene Deletion | 4 | 2013 | 2746 | 0.330 |
Why?
|
| Hypercalcemia | 1 | 2011 | 417 | 0.330 |
Why?
|
| Liver | 4 | 2020 | 7538 | 0.330 |
Why?
|
| Endocrinology | 2 | 2014 | 443 | 0.320 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2024 | 382 | 0.320 |
Why?
|
| Polymorphism, Genetic | 12 | 2013 | 4327 | 0.320 |
Why?
|
| Sex Characteristics | 10 | 2022 | 2610 | 0.310 |
Why?
|
| Genetic Techniques | 4 | 2015 | 435 | 0.310 |
Why?
|
| HLA Antigens | 2 | 2012 | 1356 | 0.310 |
Why?
|
| Puberty, Precocious | 3 | 2014 | 154 | 0.300 |
Why?
|
| Pedigree | 12 | 2015 | 4637 | 0.300 |
Why?
|
| Genetic Pleiotropy | 3 | 2022 | 181 | 0.300 |
Why?
|
| Osteoprotegerin | 1 | 2008 | 176 | 0.300 |
Why?
|
| Amino Acid Substitution | 7 | 2016 | 1795 | 0.300 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2007 | 44 | 0.290 |
Why?
|
| Receptors, Odorant | 2 | 2020 | 61 | 0.290 |
Why?
|
| Transcription Factors | 13 | 2022 | 12165 | 0.290 |
Why?
|
| Estrogen Receptor alpha | 2 | 2008 | 588 | 0.290 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2020 | 425 | 0.280 |
Why?
|
| RANK Ligand | 1 | 2008 | 325 | 0.280 |
Why?
|
| Genome | 5 | 2011 | 1806 | 0.280 |
Why?
|
| Sample Size | 2 | 2022 | 841 | 0.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 2901 | 0.270 |
Why?
|
| Galactosyltransferases | 2 | 2020 | 267 | 0.270 |
Why?
|
| Neuropeptide Y | 1 | 2007 | 200 | 0.270 |
Why?
|
| Gene Expression | 2 | 2018 | 7771 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 10 | 2020 | 2927 | 0.260 |
Why?
|
| Aromatase | 4 | 2009 | 147 | 0.260 |
Why?
|
| Testosterone | 1 | 2016 | 2457 | 0.260 |
Why?
|
| Finland | 6 | 2015 | 612 | 0.260 |
Why?
|
| Child, Preschool | 26 | 2024 | 41390 | 0.260 |
Why?
|
| Adult | 78 | 2024 | 216658 | 0.260 |
Why?
|
| Computer Simulation | 7 | 2014 | 6190 | 0.260 |
Why?
|
| Hypospadias | 2 | 2017 | 92 | 0.250 |
Why?
|
| Coronary Artery Disease | 7 | 2023 | 6565 | 0.250 |
Why?
|
| Algorithms | 9 | 2019 | 13984 | 0.250 |
Why?
|
| Genes, Recessive | 4 | 2016 | 643 | 0.250 |
Why?
|
| Phylogeny | 3 | 2019 | 2820 | 0.240 |
Why?
|
| HMGA2 Protein | 3 | 2018 | 114 | 0.240 |
Why?
|
| Chondrocytes | 2 | 2021 | 804 | 0.240 |
Why?
|
| Genetic Testing | 4 | 2017 | 3487 | 0.240 |
Why?
|
| RNA, Messenger | 7 | 2018 | 13011 | 0.240 |
Why?
|
| Nuclear Proteins | 8 | 2013 | 5851 | 0.230 |
Why?
|
| Crohn Disease | 2 | 2014 | 2321 | 0.230 |
Why?
|
| beta-Galactosidase | 2 | 2003 | 571 | 0.220 |
Why?
|
| Cholesterol, LDL | 7 | 2023 | 2385 | 0.220 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2022 | 12 | 0.220 |
Why?
|
| Gene Dosage | 6 | 2015 | 1255 | 0.220 |
Why?
|
| Carrier Proteins | 6 | 2013 | 5006 | 0.220 |
Why?
|
| Estrogen Receptor beta | 3 | 2008 | 175 | 0.210 |
Why?
|
| Cholesterol, HDL | 5 | 2013 | 1817 | 0.210 |
Why?
|
| Base Sequence | 14 | 2016 | 12769 | 0.210 |
Why?
|
| Young Adult | 28 | 2023 | 57267 | 0.210 |
Why?
|
| Risk Factors | 38 | 2024 | 73094 | 0.210 |
Why?
|
| Triglycerides | 6 | 2020 | 2465 | 0.210 |
Why?
|
| Gene Expression Profiling | 8 | 2018 | 9431 | 0.210 |
Why?
|
| Geography | 3 | 2015 | 667 | 0.200 |
Why?
|
| DNA Repair Enzymes | 2 | 2014 | 351 | 0.200 |
Why?
|
| Middle Aged | 73 | 2022 | 216054 | 0.200 |
Why?
|
| Epigenesis, Genetic | 6 | 2022 | 3686 | 0.200 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 1936 | 0.200 |
Why?
|
| Pediatrics | 2 | 2020 | 3517 | 0.200 |
Why?
|
| Leukocytes | 3 | 2019 | 2056 | 0.200 |
Why?
|
| Blood Pressure | 11 | 2016 | 8635 | 0.190 |
Why?
|
| Penetrance | 3 | 2016 | 384 | 0.190 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 15657 | 0.190 |
Why?
|
| Ribonucleoproteins | 2 | 2014 | 378 | 0.190 |
Why?
|
| Population Groups | 5 | 2021 | 208 | 0.190 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2020 | 27 | 0.190 |
Why?
|
| Albuminuria | 2 | 2015 | 670 | 0.190 |
Why?
|
| Sialyltransferases | 1 | 2020 | 75 | 0.180 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 12054 | 0.180 |
Why?
|
| Glomerular Basement Membrane | 1 | 2019 | 35 | 0.180 |
Why?
|
| Animals | 32 | 2023 | 169600 | 0.170 |
Why?
|
| Growth | 3 | 2018 | 377 | 0.170 |
Why?
|
| CpG Islands | 3 | 2022 | 1219 | 0.170 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2021 | 55 | 0.170 |
Why?
|
| Collagen Type IV | 1 | 2019 | 139 | 0.170 |
Why?
|
| Breast Neoplasms | 17 | 2011 | 20914 | 0.160 |
Why?
|
| Aged | 54 | 2020 | 165629 | 0.160 |
Why?
|
| Waist Circumference | 8 | 2017 | 924 | 0.160 |
Why?
|
| Transcription, Genetic | 7 | 2015 | 7708 | 0.160 |
Why?
|
| Glutamine | 2 | 2020 | 578 | 0.160 |
Why?
|
| Risk | 12 | 2019 | 9683 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 3 | 2020 | 1029 | 0.160 |
Why?
|
| Poland | 3 | 2007 | 184 | 0.160 |
Why?
|
| Osteoporosis | 1 | 2008 | 1582 | 0.160 |
Why?
|
| Mice | 20 | 2023 | 81766 | 0.160 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2017 | 152 | 0.160 |
Why?
|
| Hematopoiesis | 2 | 2019 | 2087 | 0.160 |
Why?
|
| Autistic Disorder | 2 | 2022 | 1174 | 0.160 |
Why?
|
| DNA Methylation | 3 | 2022 | 4315 | 0.160 |
Why?
|
| Hyperuricemia | 1 | 2021 | 210 | 0.160 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 2 | 2015 | 54 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 448 | 0.150 |
Why?
|
| Jews | 2 | 2011 | 387 | 0.150 |
Why?
|
| Wolf-Hirschhorn Syndrome | 1 | 2017 | 5 | 0.150 |
Why?
|
| Virilism | 1 | 2017 | 31 | 0.150 |
Why?
|
| DNA Helicases | 2 | 2014 | 862 | 0.150 |
Why?
|
| Odds Ratio | 10 | 2015 | 9863 | 0.150 |
Why?
|
| Biostatistics | 2 | 2019 | 162 | 0.140 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2017 | 40 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7355 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2017 | 414 | 0.140 |
Why?
|
| Acute Disease | 2 | 2018 | 7221 | 0.140 |
Why?
|
| Repressor Proteins | 7 | 2016 | 3021 | 0.140 |
Why?
|
| PPAR gamma | 2 | 2010 | 491 | 0.140 |
Why?
|
| Epidemiology | 1 | 2019 | 287 | 0.140 |
Why?
|
| Erythrocytes | 2 | 2016 | 2463 | 0.140 |
Why?
|
| Scrotum | 1 | 2017 | 121 | 0.140 |
Why?
|
| Receptors, LHRH | 2 | 2008 | 160 | 0.140 |
Why?
|
| NAD | 1 | 2020 | 596 | 0.140 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2017 | 79 | 0.140 |
Why?
|
| Sequence Deletion | 3 | 2016 | 1522 | 0.140 |
Why?
|
| Hypersensitivity | 2 | 2017 | 1123 | 0.140 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 2 | 2006 | 55 | 0.140 |
Why?
|
| Research Design | 5 | 2014 | 6118 | 0.140 |
Why?
|
| Insulin | 8 | 2015 | 6623 | 0.130 |
Why?
|
| Homozygote | 3 | 2018 | 1795 | 0.130 |
Why?
|
| Cataract | 1 | 2022 | 845 | 0.130 |
Why?
|
| RNA-Binding Proteins | 4 | 2013 | 1913 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 738 | 0.130 |
Why?
|
| Social Justice | 1 | 2020 | 465 | 0.130 |
Why?
|
| Proprotein Convertase 1 | 1 | 2015 | 10 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 288 | 0.130 |
Why?
|
| Italy | 2 | 2015 | 831 | 0.130 |
Why?
|
| Leg Bones | 1 | 2015 | 19 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 1999 | 982 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2013 | 321 | 0.130 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2007 | 98 | 0.130 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2015 | 17 | 0.130 |
Why?
|
| Ethics Committees, Research | 2 | 2019 | 195 | 0.130 |
Why?
|
| Sucrase | 1 | 2015 | 54 | 0.130 |
Why?
|
| Prostatic Neoplasms | 10 | 2009 | 11211 | 0.130 |
Why?
|
| Amylases | 1 | 2015 | 172 | 0.130 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 20026 | 0.130 |
Why?
|
| Group II Chaperonins | 1 | 2014 | 7 | 0.130 |
Why?
|
| Bone Density | 1 | 2008 | 3504 | 0.130 |
Why?
|
| Autoantigens | 1 | 2019 | 901 | 0.130 |
Why?
|
| Cockayne Syndrome | 1 | 2014 | 23 | 0.130 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2007 | 150 | 0.130 |
Why?
|
| Brugada Syndrome | 1 | 2016 | 97 | 0.120 |
Why?
|
| Adenosine Deaminase | 1 | 2017 | 243 | 0.120 |
Why?
|
| Haptoglobins | 1 | 2016 | 167 | 0.120 |
Why?
|
| United States | 19 | 2024 | 70772 | 0.120 |
Why?
|
| Cardiovascular Diseases | 10 | 2021 | 15433 | 0.120 |
Why?
|
| Genes, Developmental | 1 | 2014 | 39 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2017 | 320 | 0.120 |
Why?
|
| Genetic Drift | 1 | 2014 | 44 | 0.120 |
Why?
|
| Codon, Terminator | 1 | 2014 | 128 | 0.120 |
Why?
|
| Aggrecans | 1 | 2014 | 90 | 0.120 |
Why?
|
| Heterozygote | 3 | 2018 | 2816 | 0.120 |
Why?
|
| Exons | 6 | 2016 | 2443 | 0.120 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.120 |
Why?
|
| Erythropoiesis | 2 | 2016 | 706 | 0.120 |
Why?
|
| Chromatin | 5 | 2022 | 2960 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 1343 | 0.120 |
Why?
|
| Likelihood Functions | 3 | 2014 | 1010 | 0.120 |
Why?
|
| Quality Control | 3 | 2016 | 839 | 0.120 |
Why?
|
| Intra-Abdominal Fat | 2 | 2010 | 600 | 0.120 |
Why?
|
| Gout | 1 | 2021 | 589 | 0.120 |
Why?
|
| Receptor Activity-Modifying Proteins | 1 | 2013 | 3 | 0.120 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 135 | 0.120 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2014 | 45 | 0.120 |
Why?
|
| Intestines | 1 | 2003 | 1924 | 0.120 |
Why?
|
| Jamaica | 2 | 2010 | 51 | 0.120 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 827 | 0.120 |
Why?
|
| Immune System Diseases | 1 | 2016 | 262 | 0.120 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Point Mutation | 2 | 2014 | 1619 | 0.110 |
Why?
|
| Cardiomegaly | 1 | 2016 | 607 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2013 | 119 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2276 | 0.110 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2011 | 563 | 0.110 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2013 | 72 | 0.110 |
Why?
|
| Nutrition Assessment | 1 | 2017 | 729 | 0.110 |
Why?
|
| Causality | 1 | 2020 | 1285 | 0.110 |
Why?
|
| Heart Diseases | 2 | 2017 | 2802 | 0.110 |
Why?
|
| Isoenzymes | 2 | 2010 | 1722 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2007 | 695 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 3 | 2013 | 164 | 0.110 |
Why?
|
| Eating | 1 | 2020 | 1563 | 0.110 |
Why?
|
| Coronary Disease | 4 | 2019 | 6083 | 0.110 |
Why?
|
| Uniparental Disomy | 1 | 2012 | 43 | 0.110 |
Why?
|
| Chromosome Deletion | 2 | 2022 | 1400 | 0.110 |
Why?
|
| Energy Intake | 2 | 2017 | 2165 | 0.110 |
Why?
|
| Age of Onset | 4 | 2019 | 3290 | 0.110 |
Why?
|
| Plant Proteins | 1 | 1995 | 364 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 211 | 0.110 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 904 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2730 | 0.110 |
Why?
|
| Bone Development | 2 | 2014 | 482 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1118 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1995 | 2755 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2020 | 1402 | 0.110 |
Why?
|
| Leukocytosis | 1 | 2014 | 246 | 0.110 |
Why?
|
| Guidelines as Topic | 2 | 2014 | 1402 | 0.110 |
Why?
|
| Protein Phosphatase 1 | 1 | 2013 | 137 | 0.110 |
Why?
|
| Benchmarking | 1 | 2019 | 1048 | 0.110 |
Why?
|
| Phosphoproteins | 3 | 2007 | 2449 | 0.100 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2013 | 90 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 259 | 0.100 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1995 | 503 | 0.100 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 261 | 0.100 |
Why?
|
| Physical Chromosome Mapping | 2 | 2010 | 182 | 0.100 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2014 | 439 | 0.100 |
Why?
|
| Suppression, Genetic | 2 | 1992 | 196 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2015 | 248 | 0.100 |
Why?
|
| Prospective Studies | 11 | 2023 | 53863 | 0.100 |
Why?
|
| Sarcomeres | 2 | 2012 | 365 | 0.100 |
Why?
|
| Haploinsufficiency | 1 | 2013 | 332 | 0.100 |
Why?
|
| Age Factors | 11 | 2015 | 18460 | 0.100 |
Why?
|
| Genetic Heterogeneity | 2 | 2016 | 733 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2013 | 94 | 0.100 |
Why?
|
| Sexual Maturation | 2 | 2010 | 265 | 0.100 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 1084 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2013 | 315 | 0.100 |
Why?
|
| Hawaii | 2 | 2008 | 100 | 0.100 |
Why?
|
| Microcephaly | 2 | 2013 | 438 | 0.100 |
Why?
|
| Molecular Sequence Data | 8 | 2016 | 18050 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 5 | 2015 | 4455 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2017 | 314 | 0.100 |
Why?
|
| Birth Weight | 3 | 2020 | 2099 | 0.100 |
Why?
|
| Crossing Over, Genetic | 1 | 2011 | 95 | 0.100 |
Why?
|
| Histones | 3 | 2021 | 2615 | 0.100 |
Why?
|
| Los Angeles | 2 | 2008 | 238 | 0.100 |
Why?
|
| DNA | 5 | 2022 | 7312 | 0.100 |
Why?
|
| Energy Metabolism | 3 | 2017 | 2908 | 0.100 |
Why?
|
| Developmental Disabilities | 3 | 2015 | 1484 | 0.100 |
Why?
|
| Gene Flow | 1 | 2011 | 79 | 0.100 |
Why?
|
| Genetic Fitness | 1 | 2012 | 125 | 0.100 |
Why?
|
| Educational Status | 2 | 2016 | 2573 | 0.100 |
Why?
|
| Ion Channels | 1 | 2016 | 1051 | 0.090 |
Why?
|
| Interleukin-13 | 1 | 2013 | 397 | 0.090 |
Why?
|
| Receptors, LDL | 1 | 2013 | 480 | 0.090 |
Why?
|
| Siblings | 4 | 2011 | 850 | 0.090 |
Why?
|
| CHARGE Syndrome | 1 | 2010 | 31 | 0.090 |
Why?
|
| Genes | 3 | 2014 | 1885 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 1210 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2017 | 1552 | 0.090 |
Why?
|
| Nigeria | 2 | 2011 | 764 | 0.090 |
Why?
|
| Lipoproteins, HDL | 2 | 2013 | 659 | 0.090 |
Why?
|
| Gene Duplication | 1 | 2011 | 327 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 5799 | 0.090 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 421 | 0.090 |
Why?
|
| Diet | 4 | 2021 | 7969 | 0.090 |
Why?
|
| Pain | 2 | 2020 | 5040 | 0.090 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2009 | 715 | 0.090 |
Why?
|
| Myocardial Infarction | 5 | 2019 | 11824 | 0.090 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 54 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 433 | 0.090 |
Why?
|
| Illinois | 1 | 2010 | 120 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2011 | 227 | 0.090 |
Why?
|
| Nutritional Status | 2 | 2017 | 1610 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2011 | 195 | 0.090 |
Why?
|
| Environment | 4 | 2009 | 1123 | 0.090 |
Why?
|
| Multienzyme Complexes | 2 | 2020 | 669 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2014 | 912 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2016 | 1127 | 0.090 |
Why?
|
| Consanguinity | 1 | 2011 | 459 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 8460 | 0.090 |
Why?
|
| Lysophospholipase | 1 | 2009 | 63 | 0.090 |
Why?
|
| Infant | 8 | 2022 | 35447 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 3 | 2012 | 2729 | 0.090 |
Why?
|
| Epigenomics | 3 | 2021 | 905 | 0.090 |
Why?
|
| Arginine | 2 | 2010 | 939 | 0.090 |
Why?
|
| Insulin Resistance | 7 | 2022 | 3889 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2019 | 7805 | 0.090 |
Why?
|
| Documentation | 1 | 2015 | 888 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 2 | 2007 | 216 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2009 | 81 | 0.080 |
Why?
|
| Dyslipidemias | 2 | 2022 | 865 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 1995 | 1041 | 0.080 |
Why?
|
| Hallucinations | 1 | 2011 | 361 | 0.080 |
Why?
|
| Sequence Tagged Sites | 2 | 2006 | 94 | 0.080 |
Why?
|
| Databases, Genetic | 4 | 2019 | 1780 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2024 | 9223 | 0.080 |
Why?
|
| Adipose Tissue | 3 | 2019 | 3308 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2017 | 2766 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2018 | 2450 | 0.080 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 2 | 2020 | 57 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 477 | 0.080 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 362 | 0.080 |
Why?
|
| Evolution, Molecular | 3 | 2012 | 1947 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2022 | 349 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 1992 | 915 | 0.080 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 1988 | 24 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2020 | 3802 | 0.080 |
Why?
|
| Receptors, Prolactin | 1 | 2007 | 17 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2021 | 11553 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 326 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2018 | 3404 | 0.080 |
Why?
|
| Sweden | 3 | 2014 | 1348 | 0.080 |
Why?
|
| Mice, Inbred A | 1 | 2008 | 249 | 0.080 |
Why?
|
| Cholesterol | 2 | 2016 | 2926 | 0.080 |
Why?
|
| Lactose | 1 | 2007 | 95 | 0.080 |
Why?
|
| C-Reactive Protein | 3 | 2013 | 3814 | 0.080 |
Why?
|
| Natriuretic Peptides | 1 | 2009 | 152 | 0.080 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2007 | 70 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2009 | 387 | 0.080 |
Why?
|
| Cyclins | 1 | 2010 | 603 | 0.080 |
Why?
|
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2007 | 14 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2018 | 2191 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2020 | 64017 | 0.080 |
Why?
|
| Globins | 1 | 2008 | 415 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2015 | 377 | 0.070 |
Why?
|
| Infant, Newborn | 6 | 2016 | 25903 | 0.070 |
Why?
|
| Confidentiality | 1 | 2012 | 614 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2009 | 623 | 0.070 |
Why?
|
| Reproduction | 1 | 2012 | 673 | 0.070 |
Why?
|
| Schizophrenia | 2 | 2016 | 6923 | 0.070 |
Why?
|
| Dogs | 1 | 2012 | 3915 | 0.070 |
Why?
|
| Erythroid Cells | 1 | 2008 | 239 | 0.070 |
Why?
|
| Models, Statistical | 2 | 2014 | 5107 | 0.070 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2006 | 30 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2009 | 424 | 0.070 |
Why?
|
| Fetal Development | 1 | 2012 | 771 | 0.070 |
Why?
|
| Glucose | 5 | 2018 | 4396 | 0.070 |
Why?
|
| Income | 1 | 2016 | 1921 | 0.070 |
Why?
|
| Social Class | 1 | 2016 | 2005 | 0.070 |
Why?
|
| Glucokinase | 1 | 2007 | 103 | 0.070 |
Why?
|
| Receptors, Neuropeptide | 1 | 2007 | 112 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 1362 | 0.070 |
Why?
|
| STAT5 Transcription Factor | 1 | 2007 | 261 | 0.070 |
Why?
|
| False Positive Reactions | 2 | 2014 | 965 | 0.070 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 58361 | 0.070 |
Why?
|
| Genes, Fungal | 1 | 1988 | 453 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2006 | 123 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 139 | 0.070 |
Why?
|
| Insulysin | 1 | 2006 | 50 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 2264 | 0.070 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2007 | 213 | 0.070 |
Why?
|
| Trans-Activators | 3 | 2015 | 2912 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2006 | 172 | 0.070 |
Why?
|
| Hyperlipidemias | 1 | 2011 | 797 | 0.070 |
Why?
|
| MADS Domain Proteins | 1 | 2005 | 19 | 0.070 |
Why?
|
| Prolactin | 1 | 2007 | 673 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3218 | 0.070 |
Why?
|
| beta-Thalassemia | 1 | 2008 | 226 | 0.070 |
Why?
|
| Blood Platelets | 1 | 2016 | 2526 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14596 | 0.060 |
Why?
|
| Spine | 1 | 2012 | 1127 | 0.060 |
Why?
|
| Blood Glucose | 6 | 2011 | 6318 | 0.060 |
Why?
|
| Alanine | 2 | 2005 | 575 | 0.060 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2005 | 105 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 6 | 2017 | 5858 | 0.060 |
Why?
|
| Boston | 1 | 2018 | 9348 | 0.060 |
Why?
|
| Epidemiologic Research Design | 1 | 2008 | 366 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2017 | 1060 | 0.060 |
Why?
|
| Glycoproteins | 2 | 2017 | 2253 | 0.060 |
Why?
|
| Breast Neoplasms, Male | 1 | 2006 | 214 | 0.060 |
Why?
|
| Renin | 1 | 2007 | 646 | 0.060 |
Why?
|
| Glucose Tolerance Test | 3 | 2020 | 1168 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 2183 | 0.060 |
Why?
|
| Reference Values | 3 | 2007 | 4994 | 0.060 |
Why?
|
| Length of Stay | 1 | 2018 | 6355 | 0.060 |
Why?
|
| Atherosclerosis | 2 | 2013 | 3480 | 0.060 |
Why?
|
| Introns | 4 | 2008 | 988 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2019 | 387 | 0.060 |
Why?
|
| Syndrome | 3 | 2017 | 3261 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 281 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2011 | 2446 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2017 | 3012 | 0.060 |
Why?
|
| Linear Models | 3 | 2013 | 5965 | 0.060 |
Why?
|
| Exercise | 2 | 2019 | 5662 | 0.060 |
Why?
|
| DNA Mutational Analysis | 4 | 2015 | 4179 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 1249 | 0.060 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2023 | 15 | 0.060 |
Why?
|
| Receptors, Drug | 1 | 2004 | 162 | 0.060 |
Why?
|
| Risk Assessment | 6 | 2019 | 23554 | 0.060 |
Why?
|
| Myocardium | 1 | 2017 | 4719 | 0.060 |
Why?
|
| Internet | 2 | 2014 | 3074 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2006 | 360 | 0.060 |
Why?
|
| Janus Kinase 2 | 1 | 2007 | 533 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2006 | 836 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 377 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2005 | 370 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 3700 | 0.060 |
Why?
|
| Hemostatics | 1 | 2006 | 234 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 2846 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2010 | 834 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2017 | 246 | 0.060 |
Why?
|
| Receptors, Corticotropin | 1 | 2002 | 25 | 0.050 |
Why?
|
| Smoking | 3 | 2017 | 9030 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2005 | 475 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 472 | 0.050 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 454 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2005 | 616 | 0.050 |
Why?
|
| Electronic Health Records | 2 | 2019 | 4579 | 0.050 |
Why?
|
| Microsatellite Repeats | 2 | 2004 | 801 | 0.050 |
Why?
|
| Hypocalcemia | 1 | 2004 | 195 | 0.050 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2004 | 317 | 0.050 |
Why?
|
| Hormones, Ectopic | 1 | 2002 | 40 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 842 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2016 | 6458 | 0.050 |
Why?
|
| Stem Cells | 1 | 2015 | 3581 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1670 | 0.050 |
Why?
|
| Genomic Imprinting | 2 | 2014 | 334 | 0.050 |
Why?
|
| Forced Expiratory Volume | 2 | 2019 | 1748 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2023 | 39223 | 0.050 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 2423 | 0.050 |
Why?
|
| Breast Feeding | 1 | 2010 | 1335 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2015 | 363 | 0.050 |
Why?
|
| Publication Bias | 1 | 2003 | 162 | 0.050 |
Why?
|
| Arteries | 1 | 2007 | 1123 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2012 | 1267 | 0.050 |
Why?
|
| Aldosterone | 1 | 2007 | 882 | 0.050 |
Why?
|
| Spleen | 1 | 2008 | 2369 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2008 | 1436 | 0.050 |
Why?
|
| Weight Gain | 2 | 2023 | 2317 | 0.050 |
Why?
|
| Quebec | 1 | 2001 | 134 | 0.050 |
Why?
|
| Chromosome Segregation | 1 | 2002 | 234 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 1367 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1362 | 0.050 |
Why?
|
| Neutrophils | 1 | 2014 | 3729 | 0.050 |
Why?
|
| Vasodilation | 1 | 2005 | 946 | 0.050 |
Why?
|
| Postmenopause | 2 | 2007 | 2478 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2004 | 556 | 0.050 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2021 | 45 | 0.050 |
Why?
|
| Fibrosis | 2 | 2022 | 2028 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2021 | 78758 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2003 | 480 | 0.050 |
Why?
|
| Genes, BRCA2 | 1 | 2004 | 622 | 0.050 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 25454 | 0.050 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 14219 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2006 | 1145 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2001 | 198 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 560 | 0.050 |
Why?
|
| Lod Score | 1 | 2001 | 611 | 0.050 |
Why?
|
| Drosophila | 2 | 2019 | 1505 | 0.050 |
Why?
|
| Microfibrils | 1 | 2020 | 17 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2006 | 854 | 0.050 |
Why?
|
| Indians, South American | 1 | 2020 | 36 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 1593 | 0.050 |
Why?
|
| Cytokines | 2 | 2015 | 7400 | 0.050 |
Why?
|
| Protein Stability | 1 | 2022 | 559 | 0.050 |
Why?
|
| Skinfold Thickness | 2 | 2010 | 162 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2010 | 8413 | 0.050 |
Why?
|
| Calcium | 2 | 2011 | 5774 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 431 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 9990 | 0.050 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2020 | 93 | 0.040 |
Why?
|
| Prevalence | 5 | 2023 | 15404 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 1109 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1653 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2008 | 1049 | 0.040 |
Why?
|
| Estrogens | 1 | 2007 | 1573 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 448 | 0.040 |
Why?
|
| Heredity | 1 | 2020 | 152 | 0.040 |
Why?
|
| Exercise Test | 1 | 2007 | 2090 | 0.040 |
Why?
|
| Ovarian Neoplasms | 2 | 2008 | 4872 | 0.040 |
Why?
|
| Gout Suppressants | 1 | 2021 | 168 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 671 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2022 | 512 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4624 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2019 | 2526 | 0.040 |
Why?
|
| Hypertension | 4 | 2016 | 8614 | 0.040 |
Why?
|
| Africa | 1 | 2021 | 696 | 0.040 |
Why?
|
| Body Composition | 1 | 2008 | 2439 | 0.040 |
Why?
|
| Information Dissemination | 2 | 2019 | 1107 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2005 | 2376 | 0.040 |
Why?
|
| Biopsy | 1 | 2010 | 6771 | 0.040 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2004 | 1207 | 0.040 |
Why?
|
| Rats | 2 | 2012 | 24248 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10422 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2019 | 151 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2019 | 238 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2022 | 576 | 0.040 |
Why?
|
| Thermogenesis | 1 | 2022 | 445 | 0.040 |
Why?
|
| Leptin | 1 | 2006 | 1621 | 0.040 |
Why?
|
| Sex Factors | 4 | 2020 | 10469 | 0.040 |
Why?
|
| Alopecia | 1 | 2022 | 392 | 0.040 |
Why?
|
| Cognition | 1 | 2015 | 6844 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 1351 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2022 | 1012 | 0.040 |
Why?
|
| Fasting | 2 | 2018 | 1607 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 15 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Time Factors | 6 | 2014 | 40195 | 0.040 |
Why?
|
| Estonia | 1 | 2016 | 53 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 1830 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 106 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4228 | 0.040 |
Why?
|
| Glycerides | 1 | 2017 | 70 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 901 | 0.040 |
Why?
|
| Cytosol | 1 | 2020 | 906 | 0.040 |
Why?
|
| Histone Code | 1 | 2017 | 161 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 281 | 0.040 |
Why?
|
| Systole | 2 | 2011 | 960 | 0.040 |
Why?
|
| Diastole | 2 | 2011 | 792 | 0.040 |
Why?
|
| Abnormalities, Multiple | 2 | 2015 | 1415 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 349 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2013 | 3125 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 2881 | 0.040 |
Why?
|
| Disease Progression | 2 | 2010 | 13364 | 0.040 |
Why?
|
| Somatomedins | 1 | 2017 | 191 | 0.030 |
Why?
|
| Shal Potassium Channels | 1 | 2016 | 20 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 160 | 0.030 |
Why?
|
| Shab Potassium Channels | 1 | 2016 | 22 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 765 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2019 | 932 | 0.030 |
Why?
|
| Fathers | 2 | 2014 | 359 | 0.030 |
Why?
|
| DNA Primers | 1 | 2000 | 2880 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 857 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2016 | 146 | 0.030 |
Why?
|
| Peptides | 1 | 1988 | 4430 | 0.030 |
Why?
|
| Incidence | 4 | 2019 | 21146 | 0.030 |
Why?
|
| Micrognathism | 1 | 2015 | 59 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2015 | 1708 | 0.030 |
Why?
|
| Receptors, Tachykinin | 1 | 2015 | 25 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 404 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 271 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2010 | 22009 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2017 | 650 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2019 | 792 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3491 | 0.030 |
Why?
|
| Uric Acid | 1 | 2021 | 776 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4733 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 1779 | 0.030 |
Why?
|
| Glutamic Acid | 2 | 2015 | 1164 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 436 | 0.030 |
Why?
|
| Tachykinins | 1 | 2015 | 78 | 0.030 |
Why?
|
| Hematocrit | 1 | 2016 | 636 | 0.030 |
Why?
|
| Chaperonins | 1 | 2014 | 64 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 364 | 0.030 |
Why?
|
| Basophils | 1 | 2016 | 398 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 2015 | 148 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2192 | 0.030 |
Why?
|
| Research Personnel | 1 | 2019 | 578 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2017 | 396 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 378 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2015 | 151 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2017 | 320 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 880 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 1858 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2019 | 0.030 |
Why?
|
| Sp3 Transcription Factor | 1 | 2013 | 29 | 0.030 |
Why?
|
| Probability | 2 | 2011 | 2514 | 0.030 |
Why?
|
| Multigene Family | 2 | 2008 | 1101 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 1366 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2014 | 6699 | 0.030 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2017 | 265 | 0.030 |
Why?
|
| 5' Untranslated Regions | 2 | 2008 | 253 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2006 | 3845 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 628 | 0.030 |
Why?
|
| Age Determination by Skeleton | 1 | 2014 | 129 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 834 | 0.030 |
Why?
|
| Occupations | 1 | 2016 | 515 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2007 | 2822 | 0.030 |
Why?
|
| Platelet Count | 1 | 2016 | 784 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 491 | 0.030 |
Why?
|
| Brain | 3 | 2022 | 26598 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 766 | 0.030 |
Why?
|
| Growth Charts | 1 | 2013 | 63 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2017 | 465 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 2015 | 277 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2013 | 45 | 0.030 |
Why?
|
| TATA Box | 1 | 1992 | 128 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2014 | 6352 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2003 | 5460 | 0.030 |
Why?
|
| Multiple Sclerosis | 1 | 2007 | 3118 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2016 | 1604 | 0.030 |
Why?
|
| Zebrafish | 2 | 2014 | 3000 | 0.030 |
Why?
|
| Noonan Syndrome | 1 | 2013 | 122 | 0.030 |
Why?
|
| Ireland | 1 | 2012 | 163 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 66 | 0.030 |
Why?
|
| Overweight | 1 | 2023 | 2393 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2013 | 232 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2013 | 163 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2015 | 313 | 0.030 |
Why?
|
| Denmark | 1 | 2014 | 766 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 767 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 787 | 0.030 |
Why?
|
| Osteochondrodysplasias | 1 | 2013 | 184 | 0.030 |
Why?
|
| Thrombosis | 1 | 2006 | 3035 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 193 | 0.030 |
Why?
|
| Gambia | 1 | 2011 | 98 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 457 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2013 | 314 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 20346 | 0.020 |
Why?
|
| Protein Kinase C-alpha | 1 | 2011 | 111 | 0.020 |
Why?
|
| Neurocan | 1 | 2011 | 21 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2228 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1992 | 280 | 0.020 |
Why?
|
| Africa, Western | 1 | 2011 | 159 | 0.020 |
Why?
|
| MicroRNAs | 3 | 2012 | 3767 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2043 | 0.020 |
Why?
|
| Aging | 1 | 2010 | 8752 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 6169 | 0.020 |
Why?
|
| Neck | 1 | 2015 | 713 | 0.020 |
Why?
|
| Interleukin-11 | 1 | 2010 | 65 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2011 | 135 | 0.020 |
Why?
|
| Irritable Mood | 1 | 2011 | 183 | 0.020 |
Why?
|
| Amino Acids | 1 | 2017 | 1744 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 1614 | 0.020 |
Why?
|
| Canada | 1 | 2016 | 2081 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 182 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 855 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2012 | 477 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2016 | 19270 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2007 | 5069 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2016 | 1044 | 0.020 |
Why?
|
| Massachusetts | 3 | 2010 | 8721 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 990 | 0.020 |
Why?
|
| Greece | 1 | 2010 | 347 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 459 | 0.020 |
Why?
|
| Models, Biological | 2 | 2018 | 9569 | 0.020 |
Why?
|
| Communication | 1 | 2024 | 3815 | 0.020 |
Why?
|
| Netherlands | 1 | 2014 | 2175 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2011 | 395 | 0.020 |
Why?
|
| Confidence Intervals | 2 | 2006 | 2978 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1079 | 0.020 |
Why?
|
| Face | 1 | 2015 | 1008 | 0.020 |
Why?
|
| Gonadal Hormones | 1 | 2009 | 30 | 0.020 |
Why?
|
| Family Health | 2 | 2007 | 1279 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 76 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2015 | 1332 | 0.020 |
Why?
|
| Genes, myb | 1 | 2008 | 18 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2121 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 938 | 0.020 |
Why?
|
| Down-Regulation | 2 | 2008 | 2987 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 799 | 0.020 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2011 | 338 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 647 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 1992 | 840 | 0.020 |
Why?
|
| Erythroblasts | 1 | 2008 | 150 | 0.020 |
Why?
|
| Prognosis | 3 | 2019 | 29264 | 0.020 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2008 | 35 | 0.020 |
Why?
|
| beta-Globins | 1 | 2008 | 115 | 0.020 |
Why?
|
| gamma-Globins | 1 | 2008 | 95 | 0.020 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2008 | 114 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 1294 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2011 | 403 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2008 | 218 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4929 | 0.020 |
Why?
|
| Kallmann Syndrome | 1 | 2009 | 140 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2008 | 6458 | 0.020 |
Why?
|
| Adipocytes | 1 | 2015 | 1193 | 0.020 |
Why?
|
| Chromosomes | 1 | 2011 | 601 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2011 | 396 | 0.020 |
Why?
|
| Counseling | 1 | 2015 | 1535 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2008 | 294 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2008 | 133 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2012 | 728 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1355 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 1556 | 0.020 |
Why?
|
| Concept Formation | 1 | 2008 | 158 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 601 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2013 | 1066 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1992 | 737 | 0.020 |
Why?
|
| Health Behavior | 1 | 2019 | 2648 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2008 | 287 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1231 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 993 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 3127 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 675 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 641 | 0.020 |
Why?
|
| Pregnancy | 2 | 2010 | 29630 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7152 | 0.020 |
Why?
|
| Publishing | 1 | 2014 | 840 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1730 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 866 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 811 | 0.020 |
Why?
|
| alpha-Galactosidase | 1 | 2006 | 58 | 0.020 |
Why?
|
| Mitochondrial Myopathies | 1 | 2006 | 47 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2018 | 23512 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2017 | 2708 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2006 | 194 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 2005 | 27 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 1684 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2007 | 331 | 0.020 |
Why?
|
| Factor VII | 1 | 2006 | 139 | 0.020 |
Why?
|
| Plasminogen Activators | 1 | 2006 | 209 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 21976 | 0.020 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2006 | 123 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 3626 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1751 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2007 | 534 | 0.020 |
Why?
|
| Adiponectin | 1 | 2011 | 1108 | 0.020 |
Why?
|
| Weight Loss | 1 | 2017 | 2679 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2005 | 91 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7852 | 0.020 |
Why?
|
| Elasticity | 1 | 2007 | 661 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 999 | 0.020 |
Why?
|
| Codon | 1 | 2006 | 612 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 359 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2009 | 703 | 0.020 |
Why?
|
| Patient Selection | 1 | 2017 | 4232 | 0.020 |
Why?
|
| Hyperemia | 1 | 2005 | 226 | 0.010 |
Why?
|
| Peer Review, Research | 1 | 2007 | 334 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3500 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 722 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 11091 | 0.010 |
Why?
|
| Brachial Artery | 1 | 2005 | 368 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1731 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3349 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2175 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 1526 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 2002 | 0.010 |
Why?
|
| Urban Population | 1 | 2011 | 2031 | 0.010 |
Why?
|
| Women's Health | 1 | 2013 | 2059 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1992 | 1887 | 0.010 |
Why?
|
| Family | 1 | 2014 | 3175 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2006 | 893 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 846 | 0.010 |
Why?
|
| Plasmids | 1 | 1988 | 2316 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2006 | 606 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2007 | 952 | 0.010 |
Why?
|
| California | 1 | 2006 | 1421 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1586 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2010 | 2012 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 3761 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 239 | 0.010 |
Why?
|
| Logistic Models | 2 | 2008 | 13441 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 1426 | 0.010 |
Why?
|
| Resistin | 1 | 2002 | 170 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2007 | 1244 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 791 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1147 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6417 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18174 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2006 | 1160 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 1508 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2011 | 2766 | 0.010 |
Why?
|
| Insulin-Secreting Cells | 1 | 2007 | 896 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 2304 | 0.010 |
Why?
|
| ROC Curve | 1 | 2008 | 3558 | 0.010 |
Why?
|
| Motor Activity | 1 | 2010 | 2715 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 874 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2885 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2013 | 6037 | 0.010 |
Why?
|
| Lysine | 1 | 2004 | 1005 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2037 | 0.010 |
Why?
|
| Seizures | 1 | 2011 | 2887 | 0.010 |
Why?
|
| Proline | 1 | 2000 | 461 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 2335 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 6624 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5144 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9743 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2004 | 1812 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 1412 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 4108 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2006 | 2618 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 13042 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12250 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 6118 | 0.010 |
Why?
|
| Echocardiography | 1 | 2006 | 5117 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12423 | 0.010 |
Why?
|
| Parents | 1 | 2006 | 3448 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16789 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10057 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15164 | 0.010 |
Why?
|
| Mothers | 1 | 2000 | 2190 | 0.010 |
Why?
|
| Stroke | 1 | 2008 | 10152 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35798 | 0.000 |
Why?
|